-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Reinstates Outperform on Guardant Health, Announces $175 Price Target

Benzinga·06/26/2026 13:03:52
Listen to the news
Bernstein analyst Eve Burstein reinstates Guardant Health (NASDAQ:GH) with a Outperform and announces $175 price target.